We don’t need no stinking consent forms

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.


A healer’s first rule is ‘do no harm,’ right? Not necessarily. Growing numbers of drug researchers are heading for little-regulated Third World countries to test their wares, and the dubious ethics of some recent such trials has ignited a hot debate among doctors and scientists. The issue will be high on the agenda as the World Medical Association meets this week, reports the GUARDIAN (UK).

In one test in China, people were deliberately infected with malaria to see if it reduced the level of HIV infection. Hundreds of infants unlucky enough to be born into the control group of a study in Africa were allowed to become infected with HIV when the condition might have been prevented.

Defenders of these tests say the more stringent guidelines used in the US and other developed countries, which require the control group to be given some form of treatment, would be meaningless in poor countries. In, say, Uganda, they argue, the only alternative to the test drug is no drug, so that’s what the tests should use. “It is all well and good to create something in Uganda that simulates London or New York [by giving various treatments to all the groups in a trial], but what you get out of that is data that is no good anywhere other than London or New York,” says Robert Levine, a professor at Yale University School of Medicine.

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate